MCRB EQUITY Pharmaceutical Preparations 2027 Quantitative Forecast

Seres Therapeutics, Inc. (MCRB) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$1.41
+$0.00 (+0%)
Market Close: Nov 17, 2026
1-Year Base Target
$2.07 +46.5%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$17.00 Bull $19
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$14.45 +924.8% Undervalued
Forward P/E -0.7x • PEG 0.00
AI Quant Stance
HOLD 44/100
RSI 23.8 • MACD Converging • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for MCRB

AI Research Note

MCRB Price Forecast 2027: Our AI models project that MCRB stock will rise to approximately $2.07 by 2027. This represents a potential 46.5% growth from the current trading price of $1.41. The overall market sentiment for MCRB is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading with its most recent quarterly earnings growing by -91.9%. MCRB shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 23.8, which suggests the stock is in oversold territory. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 43.5/100
Composite Equity Stance
HOLD (Quant Score 44/100) — HOLD (+46.5% 1Y Target Upside)
Active Technical & Price Action Triggers
  • MACD converging near zero line - potential energy building
  • Volume showing distribution (CMF: -0.2677)
  • Recent pattern: Highwave pattern detected
MACD Regime: Converging
Volume Tape: Distribution

MCRB Trajectory & Forecast Curve

Projected price curve from spot ($1.41) across 30D–3Y horizons

Term Structure of Price Targets

Calibrated to Wall Street consensus curve

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $1.46 +3.7%
90 Days 1 Quarter $1.57 +11.6%
6 Months Medium-Term $1.74 +23.2%
1 Year Base Model $2.07 +46.5%
Wall Street 12M Consensus Target: $17.00

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$18.70 +1226.2%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$2.07 +46.8%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$1.45 2.8%

Downside scenario if market headwinds or disappointing results

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+924.8% Undervalued
Risk-Adjusted Consensus Fair Value: $14.45
Spot: $1.41

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) indicates MCRB trades at a discount to its forward earnings growth trajectory (924.8% implied margin of safety).

PEG Ratio
0.00
Attractive (<1.0)
Implied Fair P/E
-7.4x
Model Growth 1105.7%
Forward P/E
-0.72x
P/S Ratio (TTM)
6.48x
Rev Growth (YoY)
68.9%
EPS Growth (YoY)
-91.9%
Market Cap
$14M
52-Week High
$29.98
52-Week Low
$1.30

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Distribution
Volume Tape: Distribution

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
23.8
Oversold
MACD Signal
Bullish
Primary Trend
Downtrend
Chaikin Money Flow
-0.268
Money Flow Index
45.8
200-Day SMA
$2.93

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 5/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on MCRB shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$4.70/sh
Profit at 1Y Target
$3.70/sh
Option Writer ROI
+78.7%
Applicable Structures
Covered Call (safest) • Naked Call (risky) • Credit Spread (defined risk)
Why Options Are Flagged for Premium Selling: The $20 Call (Jan 2027) requires MCRB to exceed $24.70 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $21.00, buying out-of-the-money calls carries negative expected value (Buyers lose 78.7% even if target hits. Premium is overpriced for 147.1% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
Wall St. 1Y Target
$21.00
+147.1% vs spot
Evaluated Call Strike
$20.00
Exp: Jan 15, 2027
Call Mark Premium
$4.70
55.3% of spot price
Call Buyer Breakeven
$24.70
Above 1Y base target
Delta / Implied Prob
57.2%
Option market odds
Contract Liquidity
54 OI
Vol: 30 • Mar 20

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Moderate Alert (Options Flow)
Flow Alert Score
75/100
Tape Classification
Moderate Alert (Options Flow)
Unusual Volume Score
65.8
Implied Volatility Spike
+96.4%
Derivative Tape Readout: Short-Term Derivative Tape: Moderate unusual activity. Monitor closely. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (MCRB 2027 Outlook)

What is the MCRB stock price prediction for 2027?

Based on our AI analysis, MCRB is predicted to reach $2.07 by 2027, representing a potential 46.5% increase from the current price of $1.41.

Is MCRB stock a good buy right now?

Our analysis rates MCRB as a HOLD (AI Quant Score 43.5/100) based on current technical and fundamental indicators. With a projected 46.5% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is MCRB 52-week high and low?

MCRB has a 52-week high of $29.98 and a 52-week low of $1.30. The stock is currently trading 95.3% below its 52-week high.

What is the technical analysis for MCRB?

MCRB is currently in a downtrend trend. The RSI of 23.8 indicates the stock is oversold. Traders should monitor support and resistance levels for potential entry points.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.